Obama policy a lift for stem cell researchers
By Bernadette Tansey,
San Francisco Chronicle
| 11. 29. 2008
[ Quotes CGS's Jesse Reynolds ]
Stem cell research advocates have waited nearly eight years for the policy change President-elect Barack Obama has signaled he'll make in the early days of his administration: lifting the restrictions imposed by President Bush on federal funding for research on human embryonic stem cells.
Those limits, and earlier laws, have left stem cell labs hungering for support since the versatile human stem cells were first derived in 1998.
Such cells, often taken from extra embryos created by in vitro fertilization clinics, can morph into the specialized cells found in skin, nerves and many other tissues. Bush shared the moral objections of some religious groups and political conservatives to research on human embryos. However, the prospect of a powerful new cell replacement technology that could some day cure injury and disease has now shifted many Republicans as well as Democrats toward support for federal funding of the work.
But Obama, even if he changes the policy, may still be powerless to send much more money to stem cell researchers anytime soon because he will be taking office amid a historic global...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...